Sponsor Pipeline

Ashibio Inc Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
1
Phase 3
Active Trials by Phase
Phase 2/3
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT06508021 A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP) Fibrodysplasia Ossificans Progressiva Active, Not Recruiting
Phase 1/2
NCT07024407 A Study of Andecaliximab in People With Spinal Cord Injury at Risk for Bone Growth… Heterotopic Ossification (HO) Recruiting
Get alerts when Ashibio Inc's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free